Course Outcome (COs) B. Pharm-VII Semester
At the end semester, student will able to | |
BP702 T.1 | Define and elaborate Pilot plant, Scale up techniques, SUPAC, Platform Technology. |
BP702 T.2 | Summarize WHO guidelines for Technology transfer, protocol, granularity, QRM, Documentation and approved regulatory bodies and agencies. |
BP702 T.3 | Outline the regulatory affairs and regulatory requirements for drug approval and general consideration on IND, NDA, Investigator’s brochure, FDA and clinical studies. |
BP702 T.4 | Explain concept of quality management & certification (TQM, QbD, 6sigma, OOS, NABL, GLP) |
BP702 T.5 | Extend knowledge on regulatory requirements as CDSCO, State Licensing Authority, COPP and approval procedure for new drug. |
CO-PO Matrices of the Industrial Pharmacy I (BP702T)
COs | PO1 | PO2 | PO3 | PO4 | PO5 | PO6 | PO7 | PO8 | PO9 | PO10 | PO11 |
BP702T.1 | 3 | 3 | 3 | 1 | 3 | 3 | 3 | 1 | 1 | 3 | 3 |
BP702T.2 | 3 | 3 | 2 | 2 | 3 | 3 | 3 | 2 | 1 | 2 | 3 |
BP702T.3 | 3 | 3 | 2 | 2 | 3 | 3 | 3 | 2 | 2 | 3 | 3 |
BP702T.4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 1 | 3 |
BP702T.5 | 3 | 3 | 2 | 2 | 3 | 3 | 3 | 1 | 3 | 1 | 3 |
BP702T | 3 | 3 | 2 | 2 | 3 | 3 | 3 | 2 | 2 | 2 | 3 |
Average | 3 | 3 | 3 | 1 | 3 | 3 | 3 | 1 | 1 | 3 | 3 |
*Correlation level 1, 2 or 3 is as mentioned below:
- Slight (Low) = 1;
- Moderate (medium) = 2;
- Substantial (high) = 3
Mrs. Krishna